China may agree to buy more U.S. agriculture commodities and lift onerous trade barriers in the ongoing talks, but unless negotiators can agree on an effective way to make sure the Chinese live up to their promises, any final deal would be worthless.

FDA promises new guidance focused on clearer, simpler approvals for gene editing advances, plus help for animal biotech product developers.

In the eyes of the Trump administration, the new trade deal binding the U.S., Mexico and Canada is a model for future agreements, and nowhere is that more evident than in the pact's Agricultural Biotechnology section.

House and Senate negotiators are likely to provide another infusion of cash into rural broadband development, but an effort to repeal the Obama-era “waters of the U.S. rule” doesn’t appear likely to survive the talks on fiscal 2019 spending bills.

The European Union is now willing to restart negotiations on beef trade with the U.S., but it’s still unclear if the Europeans are willing to include any other agriculture issues in the ongoing talks aimed at avoiding an all-out trans-Atlantic trade war.

It was more than two months ago, in early May, when Commerce Secretary Wilbur Ross sat down on a Tuesday morning with Agriculture Secretary Sonny Perdue in his second-floor office suite at USDA headquarters to discuss how they could push the Europeans into lowering trade barriers on U.S. farm commodities.

Visits to urban and rural corners of China make one thing very clear: China is changing, and changing fast.

A Cornell University-sponsored training week in Illinois helps a worldwide gathering of farmers pump up to fight for better science in the lab and the field.